Helen McCluskey
Helen McCluskey's purchase track record
Helen McCluskey has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 4/25/2025 | SIG | $100K | +44.1% | +76.3% | +22.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Abercrombie & Fitch Gains Analyst Support Amid Brand Momentum. Jefferies has added Abercrombie & Fitch to its coverage, citing strong pricing power and brand momentum. BTIG also reiterated its positive stance, maintaining a $175 price target. These analyst actions highlight continued confidence in the company's growth trajectory, even as the stock trades well below its 52-week high.
Transaction History
| SIG | ▲ Buy | Grant | 16 | $0 | 8/21/2026 | View on chart |
| SIG | ▲ Buy | Grant | 3,632 | $0 | 6/26/2026 | View on chart |
| ANF | ▲ Buy | Option Exercise | 2,089 | $0 | 6/3/2026 | View on chart |
| SIG | ▲ Buy | Grant | 17 | $0 | 5/22/2026 | View on chart |
| SIG | ▲ Buy | Grant | 13 | $0 | 2/20/2026 | View on chart |
| SIG | ▲ Buy | Grant | 13 | $0 | 11/21/2025 | View on chart |
| SIG | ▲ Buy | Grant | 14 | $0 | 8/22/2025 | View on chart |
| SIG | ▲ Buy | Grant | 3,777 | $0 | 7/1/2025 | View on chart |
| ANF | ▲ Buy | Option Exercise | 780 | $0 | 6/11/2025 | View on chart |
| SIG | ▲ Buy | Open Market | 1,700 | $100K | 4/25/2025 | View on chart |
| ANF | ▼ Sell | Open Market | 3,500 | $488K | 9/5/2024 | View on chart |
| ANF | ▼ Sell | Gift | 3,500 | $0 | 9/5/2024 | View on chart |
| SIG | ▲ Buy | Grant | 3,078 | $0 | 6/28/2024 | View on chart |
| ANF | ▲ Buy | Option Exercise | 4,292 | $0 | 6/10/2024 | View on chart |
| SIG | ▼ Sell | Gift | 4,164 | $0 | 9/26/2023 | View on chart |
| SIG | ▲ Buy | Grant | 2,467 | $0 | 6/16/2023 | View on chart |
| ANF | ▲ Buy | Option Exercise | 7,565 | $0 | 6/8/2023 | View on chart |
| SIG | ▲ Buy | Grant | 2,667 | $0 | 6/17/2022 | View on chart |
| ANF | ▲ Buy | Option Exercise | 3,615 | $0 | 6/8/2022 | View on chart |
| SIG | ▼ Sell | Open Market | 3,188 | $265K | 3/22/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Signet Shares Rise 8.4% Post-Earnings; Blue Nile Partners with Royal Asscher
Signet shares have climbed 8.4% since the last earnings report, moving against a broader market dip. The company also announced that its Blue Nile brand is partnering with Royal Asscher, a move that may strengthen its product lineup. With an average analyst target of $125.90, the stock remains well below that level, sitting near its 52-week high of $110.20.
Signet Shares Rise 8.4% Post-Earnings; Blue Nile Partners with Royal Asscher. Signet shares have climbed 8.4% since the last earnings report, moving against a broader market dip. The company also announced that its Blue Nile brand is partnering with Royal Asscher, a move that may strengthen its product lineup. With an average analyst target of $125.90, the stock remains well below that level, sitting near its 52-week high of $110.20.